The Best Medicine? What’s Meaningful to Our Patients [nytimes.com]
At the age of 28, my patient was already a war-weary veteran of leukemia. When his cancer was diagnosed, we treated him with a multi-drug cocktail of chemotherapy over months, first with more intensive regimens that sidelined him from being able to work, and then with milder medicines. His leukemia came raging back, though, so we treated him again, this time with one of the new, expensive immunotherapies that has been approved recently by the Food and Drug Administration. These are not...